Literature DB >> 9848001

Painful neuropathies.

M Koltzenburg1.   

Abstract

Pain following peripheral nerve lesion appears to be a paradox because damage of primary afferent nerve fibres carrying nociceptive information should result in hypoalgesia. The very existence of neuropathic pain therefore implies fundamental changes of nociceptive processing and there have been considerable advances in the understanding of factors that precipitate neuropathic pain. This knowledge has already been harnessed for the development of novel analgesic therapies to supplement traditional treatment with anticonvulsant and antidepressants drugs which has shown clear effectiveness in systematic reviews of randomised controlled trials.

Entities:  

Mesh:

Year:  1998        PMID: 9848001     DOI: 10.1097/00019052-199810000-00014

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  11 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Standardized Profiling of The Membrane-Enriched Proteome of Mouse Dorsal Root Ganglia (DRG) Provides Novel Insights Into Chronic Pain.

Authors:  Tom Rouwette; Julia Sondermann; Luca Avenali; David Gomez-Varela; Manuela Schmidt
Journal:  Mol Cell Proteomics       Date:  2016-04-21       Impact factor: 5.911

Review 3.  Pathophysiologic mechanisms of neuropathic pain.

Authors:  B K Taylor
Journal:  Curr Pain Headache Rep       Date:  2001-04

4.  Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids.

Authors:  Victoria C J Wallace; David F Cottrell; Peter J Brophy; Susan M Fleetwood-Walker
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

5.  L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies.

Authors:  S Chiechio; A Copani; F Nicoletti; R W Gereau
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 6.  [Symptoms and pathophysiological mechanisms of neuropathic pain syndromes].

Authors:  S Lanz; C Maihöfner
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

Review 7.  Antiepileptic drugs for the treatment of neuropathic pain: a systematic review.

Authors:  María-Lucila Vargas-Espinosa; Gemma Sanmartí-García; Eduardo Vázquez-Delgado; Cosme Gay-Escoda
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-09-01

8.  Antiallodynic effect of herbal medicine yokukansan on peripheral neuropathy in rats with chronic constriction injury.

Authors:  Yasuyuki Suzuki; Hiromasa Mitsuhata; Mitsutoshi Yuzurihara; Yoshio Kase
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-08       Impact factor: 2.629

9.  Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups.

Authors:  Christian Martini; Ashraf Yassen; Erik Olofsen; Paul Passier; Malcom Stoker; Albert Dahan
Journal:  J Pain Res       Date:  2012-03-15       Impact factor: 3.133

10.  Neuroprotective effect of Azadirachta indica standardized extract in partial sciatic nerve injury in rats: Evidence from anti-inflammatory, antioxidant and anti-apoptotic studies.

Authors:  Amit D Kandhare; Anwesha A Mukherjee; Subhash L Bodhankar
Journal:  EXCLI J       Date:  2017-04-18       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.